ADVERTISEMENT
News
BioStem Technologies
10/23/2024
https://onlinelibrary.wiley.com/doi/10.1111/iwj.70096
BoStem Technologies announces breakthrough results of BioREtain-processed membranes RE-AC (AmnioWrap2) demonstrating a clear advantage in 12-week DFU healing rates compared to SoC. Results of the study have been published in the recent issue of the International Wound Journal.